21 – 30 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A novel food-based negative oral contrast agent compared with two conventional oral contrast agents in abdominal CT : a three-arm parallel blinded randomised controlled single-centre trial
Leander, Peter LU ; Stathis, Georgios ; Casal-Dujat, Lucia LU ; Boman, Karolina ; Adnerhill, Ingvar LU ; Marsal, Jan LU
; Böök, Olof
and Fork, Thomas
LU
(2022)
In European Radiology Experimental
6(1).
- Contribution to journal › Article
-
Mark
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
Bergqvist, Viktoria LU ; Holmgren, Johanna LU ; Klintman, Daniel LU and Marsal, Jan LU
(2022)
In Alimentary pharmacology & therapeutics
55(11).
p.1389-1401
- Contribution to journal › Article
-
Mark
Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
Bergqvist, Viktoria LU ; Holmgren, Johanna LU ; Klintman, Daniel LU and Marsal, Jan LU
(2022)
In Alimentary Pharmacology and Therapeutics
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
Eriksson, Carl ; Rundquist, Sara ; Lykiardopoulos, Vyron ; Udumyan, Ruzan ; Karlén, Per ; Grip, Olof LU ; Söderman, Charlotte ; Almer, Sven ; Hertervig, Erik and Marsal, Jan LU
, et al.
(2021)
In Therapeutic Advances in Gastroenterology
14.
- Contribution to journal › Article
-
Mark
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3
Siddhuraj, Premkumar LU ; Clausson, Carl Magnus LU ; Sanden, Caroline LU ; Alyamani, Manar LU ; Kadivar, Mohammad LU ; Marsal, Jan LU
; Wallengren, Joanna
LU
; Bjermer, Leif
LU
and Erjefält, Jonas S.
LU
(2021)
In Cells
10(2).
- Contribution to journal › Article
- 2020
-
Mark
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls : Is it an overlooked comorbidity?
Wallman, Johan Karlsson LU ; Mogard, Elisabeth LU
; Marsal, Jan
LU
; Andréasson, Kristofer
LU
; Jöud, Anna
LU
; Geijer, Mats
LU
; Kristensen, Lars Erik
LU
; Lindqvist, Elisabet
LU
and Olofsson, Tor
LU
(2020)
In Annals of the Rheumatic Diseases
79(1).
p.159-161
- Contribution to journal › Letter
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
Andréasson, Kristofer LU ; Neringer, Karl ; Wuttge, Dirk M. LU ; Henrohn, Dan ; Marsal, Jan LU
and Hesselstrand, Roger
LU
(2020)
In Arthritis Research and Therapy
22(1).
- Contribution to journal › Article
-
Mark
Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
Angelison, Leif LU ; Almer, Sven ; Davidsdottir, Loa ; Hammarlund, Per ; Lindgren, Stefan LU ; Hindorf, Ulf LU ; Marsal, Jan LU
and Hertervig, Erik
LU
(2020)
In Scandinavian Journal of Gastroenterology
55(2).
p.154-162
- Contribution to journal › Article
- 2019
-
Mark
Exocrine pancreatic function is preserved in systemic sclerosis
Bozovic, Gracijela LU ; Pullerits, Rille ; Ståhl, Arne ; Ydström, Kristina ; Wenger, Daniel LU
; Marsal, Jan
LU
; Thulin, Pontus
and Andréasson, Kristofer
LU
(2019)
In Arthritis Research & Therapy
21(1).
- Contribution to journal › Article
-
Mark
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis : Results from the SPARTAKUS cohort
Olofsson, Tor LU ; Lindqvist, Elisabet LU
; Mogard, Elisabeth
LU
; Andréasson, Kristofer
LU
; Marsal, Jan
LU
; Geijer, Mats
LU
; Kristensen, Lars Erik
LU
and Wallman, Johan K.
LU
(2019)
In Rheumatology (United Kingdom)
58(7).
p.1176-1187
- Contribution to journal › Article